Overview

A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis

Status:
Terminated

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients in Asia with rheumatoid arthritis (RA).

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca